Health Care & Life Sciences » Pharmaceuticals | Eyegate Pharmaceuticals Inc.

Eyegate Pharmaceuticals Inc.

Eyegate Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.19
Market Cap
$11.37 M
Shares Outstanding
45.58 M
Public Float
36.14 M

Profile

Address
271 Waverley Oaks Road
Waltham Massachusetts 02452
United States
Employees -
Website http://www.eyegatepharma.com
Updated 07/08/2019
EyeGate Pharma is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel (OBG). OBG is a topically-applied eye drop formulation that is being developed under the 510k De Novo path for devices submitted for marketing clearance to the U.

Financials

View All
Created with Highcharts 5.0.14Eyegate Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.3 8793 8791 7741 7748 3938 39313 34313 34313 21713 21710 81110 81120132014201520162017201802.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Eyegate Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.0000006696694074071 6521 6522013201420152016201720180500100015002000

Paul G. Chaney
Chairman
Stephen From
President, Chief Executive Officer & Director